The first-ever point-of-care instrument for qualitatively detecting fentanyl in human urine has been cleared for use by the U.S. Food Drug Administration and will be distributed in the United States ...

David Reeser is one of the millions of Americans whose life has been changed by the ever-evolving, fast-growing epidemic of ...

SCHOTT Pharma USA, Inc., part of SHOTT Pharma AG, a global specialty glass manufacturer based in Germany, plans to invest $371 million over the next five years to build a new production facility in ...

Charles E. Hamner, Jr., Ph.D., a former president and CEO of the North Carolina Biotechnology Center and a longtime advocate for life sciences in the state, has received the 2024 High Flyer Champion ...

The North Carolina Biotechnology Center was saddened to learn that Philip Benfey, Ph.D., an inspiring and pioneering plant geneticist and entrepreneur, passed away on Sept. 26 at the age of 70. Benfey ...

Research Triangle Park-based Opus Genetics, a clinical-stage gene therapy company devoted to treating inherited retinal diseases, has been acquired by a small ophthalmic biopharmaceutical firm with ...

Durham-based EydisBio Inc. has received an Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for EYD-001, a treatment for systemic sclerosis. This rare and debilitating ...

AgBiome has developed and commercialized its biological agricultural products by striking up alliances with larger companies in the industry. Now the company has three more partnerships, two that will ...

Jude Samulski calls genome editing “the next wave of technology to feed the world.” Samulski contributed $3 million to create the Roberts and Mikhail Distinguished Chair in Plant Genome Editing, an ...

Ad Astra Diagnostics (AAD) of Morrisville has been awarded a $5 million federal contract for the development of an improved diagnostic system to deliver faster complete blood count (CBC) test results ...

With North Carolina’s biopharmaceutical manufacturing industry continuing to expand, two college-based programs are working to stay ahead of the growth by preparing students for promising careers in ...

Shanghai-based cancer immunotherapy innovator CARsgen joined the surge of gene- and cell-based therapy companies setting up shop in North Carolina today when it announced plans to invest $157 million ...